Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients
- 1 November 2000
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 94 (6) , 673-676
- https://doi.org/10.1016/s0035-9203(00)90228-1
Abstract
The efficacy of albendazole (ABZ) treatment for human neurocysticercosis (NCC) was assessed by using a monoclonal antibody-based parasite antigen detKeywords
This publication has 19 references indexed in Scilit:
- Magnitude of the Disease Burden from Neurocysticercosis in a Developing CountryClinical Infectious Diseases, 1999
- A specific antigen-detection elisa for the diagnosis of human neurocysticercosisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Controversies in the Management of CysticercosisEmerging Infectious Diseases, 1997
- Albendazole therapy for neurocysticercosisNeurology, 1997
- Serologic Evolution of Neurocysticercosis Patients after Antiparasitic TherapyThe Journal of Infectious Diseases, 1997
- Human cysticercosis: risk factors associated with circulating serum antigens in an open community of San Luis Potosí, MexicoPathogens and Global Health, 1995
- Discrepancies Between Cerebral Computed Tomography and Western Blot in the Diagnosis of NeurocysticercosisThe American Journal of Tropical Medicine and Hygiene, 1994
- Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluidTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosisParasite Immunology, 1989
- Immunochemical detection of antigens of larval Taenia solium and anti-larval antibodies in the cerebrospinal fluid of patients with neurocysticercosisJournal of the Neurological Sciences, 1985